Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.630
+0.010 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cyclo Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$0.95
Upside
+50.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 27, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $2.6 → $0.95 | Strong Buy | Maintains | $2.6 → $0.95 | +50.79% | Aug 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $3 → $0.95 | Strong Buy → Hold | Downgrades | $3 → $0.95 | +50.79% | Aug 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +376.19% | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +376.19% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +376.19% | May 1, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $2.6 | Strong Buy | Initiates | $2.6 | +312.70% | Apr 22, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $4 | Hold → Strong Buy | Upgrades | $4 | +534.92% | Sep 27, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 21, 2023 |